Explore All Access
Check if your research matches the topics covered in Current Gene Therapy?
- Degree of match
- Common matching concepts
- Additional journal recommendations
Current Gene Therapy : Impact Factor & More
eISSN: 1875-5631pISSN: 1566-5232
Share this on:
Check your submission readiness
Find out how your manuscript stacks up against 24 technical compliance and 6 language quality checks.
Aims and Scope
Current Gene Therapy is a peer-reviewed medical journal published by Bentham Science Publishers. The editor-in-chief is Liang Cheng (Harbin Medical University Harbin, China). The focus of this journal is pre-clinical or clinical research on gene therapy. Formats of publication include original research reports, review papers, and rapid communications ("letters"). Less
Current Gene Therapy Key Metrics
CiteScore 
5.8
Eigenfactor
0.001 - 0.005
Impact Factor
< 5
SJR
Q3Genetics
SNIP
0.89
Topics Covered on Current Gene Therapy
Progeria
Central nervous system
Ovarian cancer
Anticarsia gemmatalis
RNA editing
Nuclear structure
Serotype
Human cancer
Alzheimer's disease
Glaucoma
Empagliflozin
Machine learning
Plasmid dna
Glioblastoma
Granulocyte
Rna targeting
Weight
Interferon
Gene expression
Esophageal squamous cell carcinoma
Current Gene Therapy Journal Specifications
Indexed in the following public directories
Web of Science 
Scopus 
SJR
| Overview | |
| Publisher | BENTHAM SCIENCE PUBL LTD |
| Language | English |
| Frequency | Bi-monthly |
| General Details | |
| Language | English |
| Frequency | Bi-monthly |
| Publication Start Year | 2000 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Current Gene Therapy ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Current Gene Therapy
Significance of Ribonucleoside-diphosphate Reductase Subunit M2 in Lung Adenocarcinoma.
- 1 Apr 2025
- Current gene therapy
Theranostic Potential of Bacteriophages against Oral Squamous Cell Carcinoma.
- 1 Apr 2025
- Current Gene Therapy
SLC2A3 is a Potential Factor for Head and Neck Squamous Cancer Development through Tumor Microenvironment Alteration.
- 1 Apr 2025
- Current Gene Therapy
Advancements in CRISPR-Based Therapies for Genetic Modulation in Neurodegenerative Disorders.
- 1 Feb 2025
- Current gene therapy
Deep Innovation and Application Exploration of Artificial Intelligence in the Medical Field.
- 1 Feb 2025
- Current gene therapy
Efficacy and Safety of Pembrolizumab Monotherapy or Combined Therapy in Patients with Metastatic Triple-negative Breast Cancer: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
- 1 Feb 2025
- Current gene therapy
Significance of Ribonucleoside-diphosphate Reductase Subunit M2 in Lung Adenocarcinoma.
- 1 Apr 2025
- Current gene therapy
Theranostic Potential of Bacteriophages against Oral Squamous Cell Carcinoma.
- 1 Apr 2025
- Current Gene Therapy
SLC2A3 is a Potential Factor for Head and Neck Squamous Cancer Development through Tumor Microenvironment Alteration.
- 1 Apr 2025
- Current Gene Therapy
Advancements in CRISPR-Based Therapies for Genetic Modulation in Neurodegenerative Disorders.
- 1 Feb 2025
- Current gene therapy
Deep Innovation and Application Exploration of Artificial Intelligence in the Medical Field.
- 1 Feb 2025
- Current gene therapy
Efficacy and Safety of Pembrolizumab Monotherapy or Combined Therapy in Patients with Metastatic Triple-negative Breast Cancer: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
- 1 Feb 2025
- Current gene therapy
Compare Similar Journals with Current Gene Therapy
Select Journals to Compare with Current Gene Therapy
Total journals - 9
You can select up to 3 Journals at a time
International Journal of Molecular Sciences
Publisher: MDPI
Scientific Reports
Publisher: NATURE PORTFOLIO
Cells
Publisher: MDPI
Frontiers in Immunology
Publisher: FRONTIERS MEDIA SA
Human Gene Therapy
Publisher: MARY ANN LIEBERT, INC
Frontiers in Cell and Developmental Biology
Publisher: FRONTIERS MEDIA SA
PLoS ONE
Publisher: PUBLIC LIBRARY SCIENCE
Frontiers in Oncology
Publisher: FRONTIERS MEDIA SA
Cancers
Publisher: MDPI
0 Journals Selected to compare with
Current Gene Therapy
Compare journals across 7 parameters SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
Get detailed Journal comparison report on your email by signing up
FAQs on Current Gene Therapy
How long has Current Gene Therapy been actively publishing? 
Current Gene Therapy has been in operation since 2000 till date.
What is the publishing frequency of Current Gene Therapy?
Current Gene Therapy published with a Bi-monthly frequency.
How many articles did Current Gene Therapy publish last year?
In 2023, Current Gene Therapy publsihed 36 articles.
What is the eISSN & pISSN for Current Gene Therapy?
For Current Gene Therapy, eISSN is 1875-5631 and pISSN is 1566-5232.
What is Citescore for Current Gene Therapy?
Citescore for Current Gene Therapy is 5.8.
What is SNIP score for Current Gene Therapy?
SNIP score for Current Gene Therapy is 0.89.
What is the SJR for Current Gene Therapy?
SJR for Current Gene Therapy is Q3.
Who is the publisher of Current Gene Therapy?
BENTHAM SCIENCE PUBL LTD is the publisher of Current Gene Therapy.
